Kobayashi Pharmaceutical Revenue

In the year 2025, Kobayashi Pharmaceutical had annual revenue of 165.74B JPY with 0.09% growth. Kobayashi Pharmaceutical had revenue of 53.70B in the quarter ending December 31, 2025, with 5.01% growth.

Revenue

165.74B

Revenue Growth

+0.09%

P/S Ratio

2.53

Revenue / Employee

45.85M

Employees

3,615

Market Cap

418.68B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	165.74B	142.00M	0.09%
Dec 31, 2024	165.60B	-7.86B	-4.53%
Dec 31, 2023	173.46B	7.20B	4.33%
Dec 31, 2022	166.26B	11.01B	7.09%
Dec 31, 2021	155.25B	4.74B	3.15%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Lion Corporation	422.09B
Rohto Pharmaceutical	335.80B
KOSE Holdings	330.19B
Pola Orbis Holdings	170.29B
Paltac	1,227.67B
MTG Co., Ltd.	109.56B
Pigeon	109.17B
Noevir Holdings	63.39B

Revenue Rankings